1. Methylphenidate Enhances NMDA-Receptor Response in Medial Prefrontal Cortex via Sigma-1 Receptor: A Novel Mechanism for Methylphenidate Action Chun-Lei Zhang1., Ze-Jun…

14086 • The Journal of Neuroscience, November 11, 2009 • 29(45):14086 –14099 Development/Plasticity/Repair Hyperdopaminergic Tone Erodes Prefrontal Long-Term Potential…

1 *Note: If you find errors or fail to find your abstract, please contact Brittany Nicks, the Conference Coordinator - [[email protected]] COGNITIVE AGING CONFERENCE…

EMEDICINE Background: Parkinson disease (PD) is a progressive neurodegenerative disorder associated with a loss of dopaminergic nigrostriatal neurons. It is named after James…

Dopaminergic modulation of short-term synaptic plasticity at striatal inhibitory synapses Fatuel Tecuapetla, Luis Carrillo-Reid, Jose´ Bargas*, and Elvira Galarraga Depto…

Slide 1 PHL 437/Pharmacogenomics Fourth Lecture (Parkinson’s disease) By Abdelkader Ashour, Ph.D. Phone: 4677212Email: [email protected] Slide 2 Parkinson’s disease,…

CLASSIFICATION OF ANTIPSYCHOTIC DRUGS More than 20 different antipsychotic drugs are available for clinical use, but with certain exceptions the differences between them…

CLASSIFICATION OF ANTIPSYCHOTIC DRUGS More than 20 different antipsychotic drugs are available for clinical use, but with certain exceptions the differences between them…

Slide 1Marina E. Wolf Chicago Medical School Rosalind Franklin University of Medicine & Science How do drugs of abuse rewire the motivational circuitry? Slide 2 Acute…

Dopamine and glutamate in schizophrenia: biology, symptoms and treatmentDopamine and glutamate in schizophrenia: biology, symptoms and treatment Robert A. McCutcheon1-3,